Objective
Worlwide, about 60 million people have some kind of difficulty in walking, which is related to some neurological disorder
(stroke, dementia, neuromuscular diseases, etc). Roughly 40 million of affected correspond to elders and the % is higher in
Europe. The remaining is the sum of physically disabled by cerebral palsy (14 million), neuromuscular diseases (4 million),
spinal cord injury (paraplegia and quadriplegia, 3 million) and spina bifida (3 million).
Neurological disorders affect the lower motor of the nervous system and share the progressive muscle weakness, which
lead to several walk disability, loss of autonomy and psychosocial consequences. Most therapeutic treatments are limited to
medicines and musculoskeletal rehabilitation programs, which are very expensive and limited to 15-30 min/week
rehabilitation sessions.
Active lifestyle is the most effective measure to restore the physical conditions. But the loss of muscle strength impedes the
ambulatory function. The need is for a device allowing them walking effortlessly and safely in the everyday life activities.
Based on our ARES technology, -the minimal functional unit providing synchronized joints-muscles mobility- Marsi Bionics
has developed powered orthoses for in-house rehabilitation of patients affected by muscle weakness disorders, showing a
product portfolio that covers the needs of a wide range of Neurological Disorders. Marsi products will be commercialized
under renting models allowing patients acquiring it for daily use. This technology will improve these patients life quality and
enlarge life expectancy by avoiding critical health complications of losing walking ability.
Marsi is strengthened by joining with a leading company in the current industrial market, ESCRIBANO. This alliance in the
frame of SME Phase 2 will speed up industrialization, overcome the certification barrier and minimize the time to market. As
a result, we expect to reach above 36M€ turnover in 2023 and 81 generated jobs.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences health sciences health care services eHealth
- medical and health sciences clinical medicine physiotherapy
- social sciences economics and business business and management business models
- medical and health sciences basic medicine neurology dementia
- medical and health sciences basic medicine neurology stroke
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3.1.4. - Active ageing and self-management of health
See all projects funded under this programme -
H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
See all projects funded under this programme -
H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
See all projects funded under this programme -
H2020-EU.3.1.6. - Health care provision and integrated care
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-2 - SME instrument phase 2
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-SMEInst-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
28521 RIVAS VACIAMADRID
Spain
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.